Jump to content

Harrison Stafford

Legacy Members
  • Posts

    2853
  • Joined

  • Last visited

Everything posted by Harrison Stafford

  1. That's a decent bet, BUT we're dealing with the FDA which is govt and they can screw bigtime with timelines. Having said that, the biotech sector appears to be rebounding as LABU (3x biotech ETF) has more than doubled in sp since mid-June. Should the sector continue to rebound, your calls will make you money even if the FDA hasn't made a decision. Compare a chart of LABU and IBRX. The moves are damn near identical. Of course, if the FDA has given the thumbs up before your calls expire, you'll be in high cotton. As I said, it's a decent bet, IMHO.
  2. Glad you asked. Hearing IBRX is looking for August-September to hear from the FDA on their bladder cancer treatment. In the meantime, IBRX will mirror the moves of LABU. Holding 27,800 shares of IBRX at avg cost of 9.77.
  3. I like Odorizzi………as a reliever……….maybe.
  4. Rub some dirt on it. You’ll be fine.
  5. Started watching the Colt .45's in 1962 and have followed the franchise since that time. I've never seen anything remotely resembling NY's crowd behavior toward Altuve directed at an opposing player by Houston fans. Asked my buds who are as old as I am (or older) if they'd ever seen any similar behavior and they thought I'd lost my mind (well, I am an old). Too many NY fans lack the simple grace and courtesy we take for granted in this part of the US of A.
  6. Duke’s in the Outrigger Hotel in Honolulu.
  7. Bryan Abreu is having a hell of a season and has developed into one of the ‘Stros most dependable relievers. 3rd best ERA in the bullpen and has been nails as a middle relief pitcher.
  8. She’s not going anywhere until this special operation has played out.
  9. Bought 22,500 more shares of EOSE @ 1.97 giving me a total of 32,900 shares at an avg price of 2.44. Target is 3.80-3.90. To break out, EOSE needs to take out the March high of 4.97.
×
×
  • Create New...